Fanfan J. Li
Wenzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
ARID1B mutations promote immune evasion in acute myeloid leukemia through upregulating VISTA expression.
Journal: International immunopharmacology
Published: June 11, 2026
CD244 modulates bone marrow infiltrating CD8+ T cells and serves as a prognostic and immunotherapeutic target in acute myeloid leukemia.
Journal: Leukemia research
Published: April 17, 2026
Luteoloside Inhibits the Progression and Enhances Chemosensitivity to Cytarabine in Acute Myeloid Leukemia via β-Catenin/c-Myc Axis.
Journal: Phytotherapy research : PTR
Published: July 10, 2025
SKI-606, a Src inhibitor, ameliorates benzene-induced hematotoxicity via blocking ROS/Src kinase-mediated p38 and Akt signaling pathways.
Journal: Ecotoxicology and environmental safety
Published: August 15, 2024
CD44: a cancer stem cell marker and therapeutic target in leukemia treatment.
Journal: Frontiers in immunology
Published: December 13, 2023
Matrine induces autophagic cell death by triggering ROS/AMPK/mTOR axis and apoptosis in multiple myeloma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 04, 2023
Combined inhibition of XIAP and autophagy induces apoptosis and differentiation in acute myeloid leukaemia.
Journal: Journal of cellular and molecular medicine
Published: February 08, 2023
MicroRNA-143 acts as a tumor suppressor through Musashi-2/DLL1/Notch1 and Musashi-2/Snail1/MMPs axes in acute myeloid leukemia.
Journal: Journal of translational medicine
Published: September 30, 2022
Phenotypic and genetic analyses of four cases of coagulation factor XII deficiency.
Journal: Hematology (Amsterdam, Netherlands)
Published: July 22, 2022
Development of Nectin4/FAP-targeted CAR-T cells secreting IL-7, CCL19, and IL-12 for malignant solid tumors.
Journal: Frontiers in immunology
Published: May 31, 2022
Last Updated: 09/26/2026